Skinvisible SKVI
OTC SKVI
$0.16 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Skinvisible (SKVI) EV to EBITDA (2017 - 2023)

Updated

Skinvisible's EV to EBITDA was 14.16 in Q3 2022, up 118.7% from 6.47 a year earlier and up 506.8% from the prior quarter.

Analysis

Skinvisible (SKVI) EV to EBITDA (2017 - 2023) Analysis & Trends

On a trailing twelve-month basis, Skinvisible's EV to EBITDA was 8.63 through Sep 30, 2022, up 73.2% year-over-year; for FY2021, it came in at 4.97.

  • Per Business Quant data, SKVI's EV to EBITDA in the three quarters before Q3 2022 was 2.33 (Q2 2022), 2.37 (Q1 2022) and 4.97 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn
10 Skinvisible 864,614.86 855,592.86 5,000.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 0.45
Sep 30, 2023 0.32
Jun 30, 2023 0.40
Mar 31, 2023 0.23
Dec 31, 2022 0.84
Sep 30, 2022 0.93
Jun 30, 2022 0.47
Mar 31, 2022 0.64
Dec 31, 2021 1.20
Sep 30, 2021 0.80
Jun 30, 2021 2.33
Mar 31, 2021 3.99
Jun 30, 2020 1.92
Dec 31, 2019 12.49
Sep 30, 2019 1.19
Sep 30, 2018 391.75
Jun 30, 2018 217.88
Mar 31, 2018 313.39
Dec 31, 2017 484.35
Sep 30, 2017 6,437.94
API Access

Skinvisible EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=SKVI&period=max&api_key=YOUR_API_KEY